Press release
United States Electrophysiology Devices Market Size, Company Share, Distribution Share Data and Outlook to 2025
GlobalDatas new report, United States Electrophysiology Devices Market Outlook to 2025, provides key market data on the United States Electrophysiology Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments -Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters and Electrophysiology Lab Systems.
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Get Sample Copy of this report @ https://www.marketresearchreports.biz/sample/sample/1731795
Scope
- Market size and company share data for Electrophysiology Devices market segments - Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters and Electrophysiology Lab Systems.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
- 2017 company share and distribution share data for Electrophysiology Devices market.
- Global corporate-level profiles of key companies operating within the United States Electrophysiology Devices market.
- Key players covered include Abbott Laboratories, Medtronic plc, Biosense Webster Inc, and Others.
Reasons to buy
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.
Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Electrophysiology Devices Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
Browse Complete Report with TOC @ https://www.marketresearchreports.biz/reports/1731795/united-states-electrophysiology-devices-outlook-market-research-reports/toc
3 Electrophysiology Devices Market, United States 9
3.1 Electrophysiology Devices Market, United States, Revenue ($m), 2015-2025 9
3.1.1 Electrophysiology Ablation Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 11
3.1.2 Electrophysiology Diagnostic Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 13
3.1.3 Electrophysiology Lab Systems Market, United States, Revenue ($m), by Segment, 2015-2025 15
3.2 Electrophysiology Devices Market, United States, Volume (Units), 2015-2025 18
3.2.1 Electrophysiology Ablation Catheters Market, United States, Volume (Units), by Segment, 2015-2025 20
3.2.2 Electrophysiology Diagnostic Catheters Market, United States, Volume (Units), by Segment, 2015-2025 22
3.2.3 Electrophysiology Lab Systems Market, United States, Volume (Units), by Segment, 2015-2025 24
3.3 Electrophysiology Devices Market, United States, Average Price ($), 2015-2025 27
3.4 Electrophysiology Devices Market, United States, Distribution Share by Revenue ($m), 2017 29
3.5 Electrophysiology Devices Market, United States, Company Share by Revenue ($m), 2017 30
4 Overview of Key Companies in United States, Electrophysiology Devices Market 32
4.1 Biosense Webster Inc 32
4.1.1 Company Overview 32
4.2 Abbott Laboratories 32
4.2.1 Company Overview 32
4.3 Medtronic Plc 32
4.3.1 Company Overview 32
4.4 Boston Scientific Corp 32
4.4.1 Company Overview 32
4.5 Micropace EP Inc. 33
4.5.1 Company Overview 33
4.6 Fischer Imaging Corp 33
4.6.1 Company Overview 33
5 Electrophysiology Devices Market Pipeline Products 34
6 Financial Deals Landscape 35
6.1 Acquisition 35
6.1.1 NN Acquires Bridgemedica 35
6.1.2 Becton, Dickinson Acquires C. R. Bard for USD24 Billion 36
6.2 Debt Offerings 39
6.2.1 Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028 39
6.3 Equity Offerings 41
6.3.1 Corindus Vascular Robotics to Raise USD25 Million in Private Placement of Preferred Shares and Warrants 41
6.3.2 BioSig Technologies Raises USD4.5 Million in Private Placement of Shares 43
6.3.3 MC10 Raises Funds through Private Placement of Shares 44
6.3.4 MRI Interventions Raises USD13.3 Million in Private Placement of Units 45
6.3.5 BioSig Technologies Raises USD4.3 Million in Private Placement of Shares 47
6.4 Venture Financing 48
6.4.1 MC10 Raises USD15 Million in Venture Financing 48
6.4.2 BioSig Technologies Raises USD2 Million in Venture Financing 49
6.4.3 MC10 Raises Additional USD2 Million in Venture Financing 50
6.4.4 MC10 Raises USD7.3 Million in Venture Financing 51
6.4.5 BioSig Technologies Raises USD1.6 Million in Venture Financing 52
View Sample PDF @ https://www.marketresearchreports.biz/reports/1731795/united-states-electrophysiology-devices-outlook-market-research-reports.pdf
7 Recent Developments 53
7.1 Corporate Communications 53
7.1.1 Mar 05, 2018: AblaCor Appoints Lawrence Rosenthal To Its Scientific Advisory Board 53
7.1.2 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman 53
7.1.3 Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors 53
7.1.4 Jan 03, 2018: BioSig Technologies Appoints New CFO to Facilitate Growth Trajectory 54
7.1.5 Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer 54
7.1.6 Nov 14, 2017: BioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA Submission 55
7.1.7 Nov 10, 2017: IP veteran Andrew Filler joins BioSig Technologies Board of Directors 55
7.1.8 Oct 25, 2017: Harvard Bioscience Appoints Katherine Eade and Thomas Loewald to the Board of Directors 56
7.1.9 Oct 11, 2017: BioSig Technologies Welcomes Joseph W. Rafferty as Chief Commercialization Officer 56
7.1.10 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 57
7.1.11 Sep 11, 2017: An opportunity to evaluate and speed-up new projects - Meet GE Healthcare at the Uppsala BIO booth 57
7.1.12 Aug 08, 2017: John K. Bakewell Joins Corindus Vascular Robotics Board of Directors 58
7.1.13 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 58
7.1.14 Jul 18, 2017: AtriCure Announces Hiring of Chief Technology Officer 58
7.1.15 Jul 17, 2017: Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer 59
7.1.16 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 60
7.1.17 Jun 07, 2017: Harvard Bioscience Elects James Green as Chairman of Board of Directors 60
7.1.18 May 31, 2017: BioSig Technologies Welcomes Natasha Russkina as Managing Director, Europe 61
7.1.19 May 26, 2017: Merit Medical Announces Appointment of New Director 61
7.2 Financial Announcements 62
7.2.1 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 62
7.2.2 Mar 14, 2018: Corindus Reports Fourth Quarter and Full Year 2017 Results 63
7.2.3 Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results 64
7.2.4 Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results 65
7.2.5 Feb 22, 2018: Integer Holdings Reports Results for Fourth Quarter and Full Year 2017 66
7.2.6 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 67
7.2.7 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 68
7.2.8 Jan 08, 2018: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017 69
7.2.9 Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results 69
7.2.10 Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results 69
7.2.11 Nov 07, 2017: Corindus Vascular Robotics Reports Third Quarter 2017 Results 70
7.2.12 Nov 01, 2017: AtriCure Reports Third Quarter 2017 Financial Results 71
7.2.13 Oct 26, 2017: Harvard Bioscience Reports Third Quarter 2017 Financial Results 72
7.2.14 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 73
7.2.15 Oct 26, 2017: Integer Holdings Reports Third Quarter 2017 Results 74
7.2.16 Oct 25, 2017: Bard Announces Third Quarter Results 75
7.2.17 Oct 25, 2017: Merit Medical Reports Results for Third Quarter 2017 76
7.2.18 Oct 16, 2017: Kura Oncology Announces Late-Breaking Presentations for Tipifarnib in HRAS Mutant Squamous Head and Neck Cancer at Upcoming AACR-NCI-EORTC International Conference 77
7.2.19 Sep 26, 2017: DFB Soria Gives Update on Enrollment in Phase 2 Clinical Trial of SOR007 (Nanoparticle Paclitaxel) Ointment for Actinic Keratosis (AK) 78
7.2.20 Sep 09, 2017: Teva Showcases Data Demonstrating Potential of Fremanezumab to Address Significant Unmet Need in Patients with Chronic and Episodic Migraine 79
7.2.21 Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 81
7.2.22 Aug 08, 2017: Corindus Vascular Robotics Reports Second Quarter 2017 Results 82
7.2.23 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 83
7.2.24 Jul 27, 2017: AtriCure Reports Second Quarter 2017 Financial Results 84
7.2.25 Jul 27, 2017: Harvard Bioscience Reports Second Quarter 2017 Financial Results 84
7.2.26 Jul 27, 2017: Integer Holdings Reports Second Quarter 2017 Results 85
7.2.27 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 86
7.2.28 May 09, 2017: Corindus Vascular Robotics Reports First Quarter 2017 Results 87
7.2.29 May 08, 2017: Integer Holdings Reports First Quarter 2017 Results 88
7.2.30 May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results 89
7.2.31 May 04, 2017: AtriCure Reports First Quarter 2017 Financial Results 89
7.2.32 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 90
7.2.33 Apr 27, 2017: Harvard Bioscience Reports First Quarter 2017 Financial Results 91
7.2.34 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 91
7.2.35 Apr 23, 2017: Bard Announces First Quarter Results 92
7.2.36 Apr 17, 2017: Lixte Biotechnology's Protein Phosphatase 2A Inhibitor, LB-100, Reported to be a Potentiator of Immunotherapy in an Animal Model 93
7.3 Other Significant Developments 94
7.3.1 Mar 06, 2018: V ClinBio Partners with Camargo for Strategic 505(b)(2) Development of CLX-103 94
7.3.2 Feb 22, 2018: Integer Announces Strategy Focused on Portfolio Management and Operational Excellence; Aligns Senior Management to Execute Strategic Imperatives 95
7.3.3 Dec 21, 2017: BioSig Technologies Issues Shareholder Letter for 2017 96
7.3.4 Nov 02, 2017: BioSig Technologies Partners with Sherpa Technology Group 96
7.3.5 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 97
7.3.6 Jun 01, 2017: Hitachi Healthcare Americas Partners with the WVU Heart and Vascular Institute to Advance the Evaluation of Left Ventricular Mechanical Function 98
7.4 Strategy And Business Planning 99
7.4.1 Nov 20, 2017: DBV Technologies Announces Positive Topline Safety Results from REALISE Phase III Trial of Viaskin Peanut for the Treatment of Peanut-Allergic Patients 99
7.4.2 Sep 11, 2017: An opportunity to evaluate and speed-up new projects - Meet GE Healthcare at the Uppsala BIO booth 100
About us
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Electrophysiology Devices Market Size, Company Share, Distribution Share Data and Outlook to 2025 here
News-ID: 1027078 • Views: …
More Releases from MarketResearchReports.biz
Hydro-flyers Market: Moving Towards a Brighter Future
A hydro-flyer is an adventure sporting device which uses the propulsion of water jet technology to create continuous flight movement, where the lift and movement are controlled by the flyer. Hydro-flyers sporting devices make use of the flow of water power to drive the flyer to reach soaring heights. The rise in water sporting facilities is one of the major factors that promote the growth and demand for hydro-flyers in…
Outdoor Floodlights: Technology and Market Dynamics
Outdoor floodlights is a reliable, highly efficient, and economical solution for a wide range of outdoor applications. These lights are resistant to temperature fluctuations and they remain stable even in extreme climatic conditions. Unlike the traditional lights, floodlights remain stable and functional even in harsh climatic conditions. This makes them ideal for use in any climate and any outdoor application. Outdoor floodlights save a significant amount of energy and consume…
Snow Helmets Market Future Prospects and Regional Outlook
Riders are riding faster and getting bolder day by day. Hence, safety equipment need to be updated as per the requirement and changing time. Earlier, helmets were primarily used by extreme skiers and racers. They were used only on slopes. However, later, the use of helmets was made compulsory. Earlier, bulky black helmets were used by riders, which are outdated at present. Currently, new stylish helmets that can match with…
Predictions for 2019: Global Sparkling Water Dispensers Industry Is Set to Boom
Sparkling water dispensers are equipment used for dispensing carbonated water. These dispensers mix the still, filtered water with carbon dioxide before dispensing. Sparkling water dispensers are mostly used in households and commercial establishments such as amusement parks, hotels, restaurants, and sports arenas. A sparkling water dispenser has separate outlets for hot water and cold water. The hot water outlet does not require a separate filtration process. However, cold water is…
More Releases for Quarter
Automotive Electric Quarter-turn Actuators Market
New Jersey, United States - The research provides a thorough and precise analysis of the global Automotive Electric Quarter-turn Actuators market, taking into account a number of variables like geographical growth, segmentation, and market size by value and volume. This is a superb research study that was especially put together to give the most recent information on important elements of the Global Automotive Electric Quarter-turn Actuators. The study offers a variety…
The Devonshire Quarter Dental Practice
The Devonshire Quarter Dental Practice offers a very relaxed and friendly environment. Whether you would like a dental check up or a full smile makeover, with options such as teeth whitening and cosmetic dentistry treatments, The Devonshire Quarter Dental Practice in Sheffield offers it all.
Teeth Whitening
There can be many reasons why teeth can be discoloured; it could be due to stain-inducing food and drinks, such as coffee, red wine,…
Wolfestone Break Quarter Record Sales
Swansea, United Kingdom (18 May, 2011) - Wolfestone, a leading language translation company offering translation services across all languages, recently secured several large contracts which has allowed them to break previous records of sales for the last quarter.
Wolfestone, the largest translation company in Wales, can provide a variety of international translation services, such as website translations, technical translations and proofreading services. This multi-award winning company is committed to delivering high…
FOURTH QUARTER RESULTS 2008
ANTWERP, Belgium, 20th January 2009 – The executive committee of Euronav NV (EURONEXT BRUSSELS: EURN) today reported its preliminary financial results for the fourth quarter and full year 2008:
The company had a net result of USD 36 million (fourth quarter 2007: USD -12.1 million) for the 3 months ended 31st December 2008 or USD 0.72 per share (fourth quarter 2007: USD -0.23 per share). EBITDA was USD 130.1 million (fourth…
Euronav - Fourth Quarter 2007 Results
ANTWERP, 22nd January 2008 – The executive committee of Euronav NV (EURONEXT BRUSSELS: EURN) reported today its preliminary financial results for the fourth quarter and full year 2007.
The company had a net result of USD –12.1 million (4Q06: USD 38.4m) for the 3 months ended 31st December 2007 or USD -0.23 per share (4Q06: USD 0.73/share). EBITDA was USD 48.6 million (4Q06: USD 95m).
For the year ending 31 December 2007,…
ANOTHER OUTSTANDING QUARTER FOR CMB
CMB’s executive committee has discussed the preliminary results recorded for the second quarter and those for the first half of 2007.
The consolidated profit after taxation for the first half of 2007 amounts to EUR 148 million (2006: EUR 68 million).
Bocimar contributes EUR 146 million to the consolidated result for the first half of 2007 (2006: EUR 59 million).
Bocimar’s result takes into account capital gains, for a total amount of EUR…
